BeStock  
Stocks › Medical Devices › SIBN

Si-Bone SIBN

US equityMarket cap rank #3109Medical Devices
$23.73 −$0.02 (-0.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $24.40 +2.82%
Open$23.55
Prev close$23.75
Day range$23.53 – $24.40
Volume801.1K
Market cap$1.07B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$55.70M+14.5% YoY
Operating profit-$4.35M+19.2% YoY
Net profit-$3.62M+20.7% YoY
Diluted EPS-$0.08+27.3% YoY
Free cash flow-$427,000.00+31.1% YoY
Operating cash flow$5.94M

Revenue, last 8 quarters

$49.0MDec '24$47.3MMar '25$48.6MJun '25$48.7MSep '25$56.3MDec '25$52.6MMar '26$56.0MJun '26$55.7MSep '26

Net profit, last 8 quarters

$-4.5MDec '24$-6.5MMar '25$-6.2MJun '25$-4.6MSep '25$-1.6MDec '25$-4.3MMar '26$-4.1MJun '26$-3.6MSep '26

Diluted EPS by quarter

-0.11Dec '24-0.15Mar '25-0.14Jun '25-0.11Sep '25-0.04Dec '25-0.10Mar '26-0.09Jun '26-0.08Sep '26

Free cash flow by quarter

$-1.1MDec '24$-7.0MMar '25$-1.9MJun '25$-620.0KSep '25$440.0KDec '25$-3.4MMar '26$-768.0KJun '26$-427.0KSep '26

Annual revenue

$73.4MFY20$90.2MFY21$106.4MFY22$138.9MFY23$167.2MFY24$200.9MFY25

Profitability & balance sheet

Gross margin79.4%
Operating margin-7.6%
Net margin-6.2%
Return on equity-7.7%
Return on assets-5.6%
Return on invested capital-7.7%
Current ratio7.58
Liabilities / assets28.1%
Cash & investments$146.26M
Total debt$42.47M
Net cash (debt)$103.79M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $55.70M $56.01M $52.59M $200.93M $56.35M
Total Operating Revenue $55.70M $56.01M $52.59M $200.93M $56.35M
Cost of Revenue $11.54M $11.46M $10.64M $41.05M $11.82M
Gross Profit $44.17M $44.55M $41.94M $159.88M $44.53M
Operating Expense $48.52M $49.35M $47.04M $182.21M $46.99M
Selling and Admin Expenses $43.96M $44.13M $42.85M $164.76M $42.63M
-Selling & Marketing Expense $33.85M $34.02M $32.81M $124.22M $32.81M
-General & Admin Expense $10.11M $10.11M $10.04M $40.54M $9.83M
Research & Development $4.56M $5.22M $4.19M $17.45M $4.36M
Operating Profit -$4.35M -$4.81M -$5.09M -$22.33M -$2.46M
Net Non-Operating Interest Income (Expense) $740,000.00 $734,000.00 $758,000.00 $3.45M $817,000.00
Non-Operating Interest Income $1.35M $1.33M $1.35M $6.07M $1.45M
Non-Operating Interest Expense $608,000.00 $598,000.00 $592,000.00 $2.63M $630,000.00
Other Income (Expense) -$9,000.00 -$16,000.00 $1,000.00 -$20,000.00 $2,000.00
Other Non-Operating Income (Expenses) -$9,000.00 -$16,000.00 $1,000.00 -$20,000.00 $2,000.00
Pretax Profit -$3.62M -$4.09M -$4.33M -$18.90M -$1.64M
Net Profit -$3.62M -$4.09M -$4.33M -$18.90M -$1.64M
Profit from Continuing Operations -$3.62M -$4.09M -$4.33M -$18.90M -$1.64M
Net Income to Parent Company -$3.62M -$4.09M -$4.33M -$18.90M -$1.64M
Net Income to Common Stockholders -$3.62M -$4.09M -$4.33M -$18.90M -$1.64M
Basic EPS -$0.08 -$0.09 -$0.10 -$0.44 -$0.04
Diluted EPS -$0.08 -$0.09 -$0.10 -$0.44 -$0.04

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $256.77M $248.76M $242.72M $238.56M $238.56M
Total Current Assets $224.65M $219.91M $214.72M $216.12M $216.12M
Cash and Cash Equivalents & Short-Term Investments $146.26M $145.94M $144.68M $147.82M $147.82M
-Cash and Cash Equivalents $35.31M $33.13M $33.54M $42.24M $42.24M
-Short Term Investments $110.95M $112.81M $111.15M $105.58M $105.58M
Receivables $31.47M $31.18M $31.56M $29.92M $29.92M
-Accounts Receivable $31.47M $31.18M $30.96M $29.92M $29.92M
Inventory $42.35M $38.39M $35.53M $33.90M $33.90M
Other Current Assets $4.57M $4.40M $2.94M $4.48M $4.48M
Total Non-Current Assets $32.12M $28.85M $28.00M $22.44M $22.44M
Net PPE $31.92M $28.63M $27.78M $22.39M $22.39M
-Gross PPE $59.18M $54.28M $51.91M $44.93M $44.93M
-Accumulated Depreciation -$27.27M -$25.65M -$24.13M -$22.55M -$22.55M
Other Non-Current Assets $204,000.00 $216,000.00 $217,000.00 $55,000.00 $55,000.00
Total Liabilities $72.09M $66.41M $63.78M $61.02M $61.02M
Total Current Liabilities $29.62M $24.04M $21.49M $25.28M $25.28M
Payables $10.50M $8.54M $6.76M $4.63M $4.63M
-Accounts Payable $10.50M $8.54M $6.76M $4.63M $4.63M
Current Accrued Expenses $5.12M $4.56M $5.00M $4.92M $4.92M
Short-Term Debt and Capital Lease Obligation $331,000.00 $426,000.00 $658,000.00 $944,000.00 $944,000.00
-Current Capital Lease Obligation $331,000.00 $426,000.00 $658,000.00 $944,000.00 $944,000.00
Other Current Liabilities $922,000.00 $889,000.00 $1.01M $879,000.00 $879,000.00
Total Non-Current Liabilities $42.47M $42.37M $42.29M $35.74M $35.74M
Long Term Debt and Capital Lease Obligation $42.47M $42.37M $42.29M $35.74M $35.74M
-Long Term Debt $35.66M $35.63M $35.60M $35.57M $35.57M
-Long Term Capital Lease Obligation $6.81M $6.74M $6.69M $175,000.00 $175,000.00
Total Equity $184.68M $182.35M $178.94M $177.53M $177.53M
Stockholders' Equity $184.68M $182.35M $178.94M $177.53M $177.53M
Capital Stock $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00
-Common Stock $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $646.70M $640.64M $633.03M $626.97M $626.97M
Retained Earnings -$462.30M -$458.68M -$454.59M -$450.26M -$450.26M
Gains/Losses Not Affecting Retained Earnings $282,000.00 $387,000.00 $501,000.00 $816,000.00 $816,000.00
-Accrued Interest Receivable – – $600,000.00 – –

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $5.94M $777,000.00 -$2.36M -$675,000.00 $1.73M
Net cash flow from continuing operations $5.94M $777,000.00 -$2.36M -$675,000.00 $1.73M
Net Income from Continuing Operations -$3.62M -$4.09M -$4.33M -$18.90M -$1.64M
Gain/Loss from Continuing Operations $23,000.00 $254,000.00 $332,000.00 $1.63M $185,000.00
Depreciation & Depletion & Amortization $1.69M $1.68M $1.62M $5.77M $1.64M
Other Non-Cash Items $210,000.00 -$60,000.00 $119,000.00 $687,000.00 $62,000.00
Change in Working Capital $2.46M -$2.60M -$5.95M -$14.33M -$4.09M
-Change in Receivables -$302,000.00 -$300,000.00 -$1.14M -$3.03M -$3.39M
-Change in Inventory -$4.09M -$2.81M -$2.04M -$8.68M $1.65M
-Change in Prepaid Assets -$155,000.00 -$860,000.00 $777,000.00 -$1.03M -$1.45M
-Change in Payables and Accrued Expense $7.01M $1.37M -$3.54M -$1.58M -$902,000.00
Net cash flow from investing -$4.08M -$2.74M -$6.23M $4.16M $13.03M
Net Cash Flow from Continuing Investing Activities -$4.08M -$2.74M -$6.23M $4.16M $13.03M
Net PPE Purchase and Sale -$6.37M -$1.55M -$1.08M -$8.41M -$1.29M
Net Investment Purchase and Sale $2.29M -$1.19M -$5.16M $12.57M $14.31M
Financing Cash Flow $347,000.00 $1.63M $34,000.00 $3.38M $1.03M
Net Cash Flow from Continuing Financing Activities $347,000.00 $1.63M $34,000.00 $3.38M $1.03M
Proceeds from Stock Option Exercised $347,000.00 $1.63M $34,000.00 $3.38M $1.03M
Ending Cash Balance $35.31M $33.13M $33.54M $42.24M $42.24M
Net Change in Cash $2.21M -$333,000.00 -$8.56M $6.86M $15.78M
Beginning Cash Balance $33.13M $33.54M $42.24M $34.95M $26.49M
Effect of Exchange Rate Changes -$24,000.00 -$74,000.00 -$145,000.00 $431,000.00 -$30,000.00
Free Cash Flow -$427,000.00 -$768,000.00 -$3.44M -$9.09M $440,000.00
Net Issuance Payments Of Debt – – – $0.00 –
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on SIBN.

Sign in to join the discussion.

Scroll to Top